Genetron Holdings Limited
GTH · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $651 | $532 | $424 | $323 |
| % Growth | 22.3% | 25.3% | 31.2% | – |
| Cost of Goods Sold | $369 | $194 | $164 | $178 |
| Gross Profit | $281 | $338 | $260 | $145 |
| % Margin | 43.2% | 63.5% | 61.3% | 44.8% |
| R&D Expenses | $290 | $254 | $149 | $92 |
| G&A Expenses | $267 | $227 | $126 | $117 |
| SG&A Expenses | $631 | $570 | $373 | $371 |
| Sales & Mktg Exp. | $365 | $343 | $247 | $254 |
| Other Operating Expenses | -$9 | -$5 | -$9 | -$11 |
| Operating Expenses | $913 | $819 | $514 | $452 |
| Operating Income | -$632 | -$481 | -$254 | -$307 |
| % Margin | -97.1% | -90.4% | -59.7% | -94.8% |
| Other Income/Exp. Net | -$109 | $21 | -$2,801 | -$367 |
| Pre-Tax Income | -$811 | -$503 | -$3,069 | -$676 |
| Tax Expense | $73 | -$64 | -$2,871 | -$355 |
| Net Income | -$884 | -$438 | -$198 | -$321 |
| % Margin | -135.8% | -82.4% | -46.7% | -99.4% |
| EPS | -28.53 | -4.76 | -3.29 | -4.65 |
| % Growth | -499.4% | -44.7% | 29.2% | – |
| EPS Diluted | -28.53 | -4.76 | -3.29 | -4.65 |
| Weighted Avg Shares Out | 31 | 92 | 60 | 69 |
| Weighted Avg Shares Out Dil | 31 | 92 | 60 | 69 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $21 | $28 | $0 |
| Interest Expense | $111 | $5 | $6 | $5 |
| Depreciation & Amortization | $85 | $21 | -$2,795 | -$319 |
| EBITDA | -$651 | -$460 | -$202 | -$626 |
| % Margin | -100.1% | -86.5% | -47.5% | -193.5% |